Results
20,923 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Camblong JurgiDirector, Chief Executive Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $18K 3,732 sh | Apr 14, 2026 traded Apr 10, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $18K 3,732 sh | Apr 14, 2026 traded Apr 10, 2026 | |
Menu PhilippeChief Medical Officer |
| SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan |
| SELL |
| $17K 3,725 sh |
| Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $40K 8,500 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 16 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $11K 2,400 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 13 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $21K 4,442 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $4,764 1,000 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $16K 3,400 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $16K 3,400 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Moll Laurent RChief Operating Officer |  AIPArteris, Inc.Open-market sale · 10b5-1 plan | SELL | $20K 990 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 13 | Moll Laurent RChief Operating Officer | AIPArteris, Inc. Open-market sale · 10b5-1 plan | SELL | $20K 1,003 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $21K 4,399 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $4,830 1,014 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 12 | Hung PriscillaDirector |  VEEVVEEVA SYSTEMS INCOpen-market sale · 10b5-1 plan | SELL | $115K 750 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 12 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER |  FROGJFrog LtdOpen-market sale · 10b5-1 plan | SELL | $387K 8,973 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 12 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | FROGJFrog Ltd Open-market sale · 10b5-1 plan | SELL | $252K 5,927 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 11 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $1.07M 1,860 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 10 | McCallion Kevin J.SVP, Products and Production |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $19K 2,693 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $780K 1,354 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $838K 1,457 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 8 | Lewis BryanDirector, CEO/President |  IDNIntellicheck, Inc.Open-market sale · 10b5-1 plan | SELL | $80K 10.0K sh | Apr 14, 2026 traded Apr 13, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $925K 1,603 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 7 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $1.15M 9,593 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 7 | Sevalia Piyush BSee Remarks |  SITMSITIME CorpOpen-market sale · 10b5-1 plan | SELL | $530K 1,247 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 7 | Murry Stefan J.Chief Financial Officer |  AAOIAPPLIED OPTOELECTRONICS, INC.Open-market sale · 10b5-1 plan | SELL | $546K 4,000 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 6 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | FROGJFrog Ltd Open-market sale · 10b5-1 plan | SELL | $4,437 100 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 4 | Navratil TomasCHIEF DEVELOPMENT OFFICER |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $144K 1,237 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 4 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $359K 2,959 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 4 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $826K 6,850 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $693K 1,210 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 4 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $73K 614 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $347K 601 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $660K 1,154 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $123K 1,100 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $208K 1,875 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $178K 1,500 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $157K 1,423 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $70K 600 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 1 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale · 10b5-1 plan | SELL | $3,847 32 sh | Apr 14, 2026 traded Apr 10, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $232K 400 sh | Apr 14, 2026 traded Apr 13, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $65K 600 sh | Apr 14, 2026 traded Apr 10, 2026 |